GlassScriptPhysician profile
Norine M Tracy
NPI 1982609202
$3,948.84
in general payments reported to CMS, 2019-2025
38 companies · $617 in 2025
The $617 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $946 · 2020: $435 · 2021: $181 · 2022: $703 · 2023: $441 · 2024: $626 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,683.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $750.67 | 2021-2025 | Qulipta, Vraylar, Ubrelvy |
| Pfizer INC. | $357.72 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $356.81 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $299.80 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $261.12 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $254.19 | 2019-2025 | Trelegy Ellipta |
| Allergan, INC. | $185.67 | 2019-2020 | |
| Amgen INC. | $183.72 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $154.21 | 2019-2025 | Capvaxive, Gardasil 9, Vaxelis |
| Sanofi-Aventis U.S. LLC | $130.54 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.55 | 2019-2024 | Jardiance, Ofev |
| Takeda Pharmaceuticals U.S.A., INC. | $67.43 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.86 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $56.82 | 2019 | |
| Edwards Lifesciences Corporation | $51.84 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Norine Tracy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.